These observations, together with the reported correlations between CD8+ T cell–tumour cell proximity and immunotherapy response described above, prompted us to investigate whether heterotypic clusters between CD8+ T cells and tumour cells can also be isolated directly from clinical cancer specimens. The gene discussed is CD8A; the disease is cancer.